SBC Medical Group Holdings Incorporated

NASDAQ:SBC

Consulting Services

Industrials
$6.27 +1.17%

+$0.04 today

Market cap
$644.85M
Beta
0.59
P/E (TTM)
7.6
EPS (TTM)
$0.40
52W Low $2.78High $5.75

Volume 0.56M

Average 0.12M

Financial health

SBC Medical Group Holdings Incorporated financial health

Start with the overall verdict and the rule-based risk checks for SBC, then work through liquidity, debt, balance-sheet quality, and claims on cash.

Financial health snapshot

Resilient

Debt service and balance sheet cushion look healthy, even if some working-capital ratios deserve context.

Cash and investments cover debt Healthy short-term liquidity Moderate leverage Interest well covered

Cash & Investments

$168.50M

Debt Cushion

$116.60M

Current Ratio

3.8x

Interest Coverage

154.3x

Risk checks

2 of 11 flagged

  • Debt growth in line with sales

    47.4% vs -0.1%

    Passes when: 3-year debt growth is no more than 5 points above revenue growth

  • Limited dilution

    +89.8%/yr

    Passes when: Diluted share count grows less than 2% a year

  • Positive equity

    Positive

    Passes when: Shareholders' equity is above zero

  • Interest covered

    226.6×

    Passes when: Operating income is at least 1.5× interest expense

  • Short-term liquidity

    3.8×

    Passes when: Current assets are at least 1× current liabilities

  • Near-term debt covered

    11.4×

    Passes when: Cash and short-term investments cover debt due within 12 months

  • Manageable net debt

    Net cash

    Passes when: Net debt is below 3× EBITDA

  • Debt repayable from cash flow

    1.2 yrs

    Passes when: Free cash flow could repay all debt within 5 years

  • Tangible equity base

    24.5%

    Passes when: Goodwill and intangibles are below 50% of equity

  • Stable Altman Z-Score

    7.73 → 4.74

    Passes when: Z-Score is not falling while below the 2.99 safe zone

  • Contained stock compensation

    0.0%

    Passes when: Stock-based compensation is below 20% of operating cash flow

Financial strength scores

How strong are the fundamentals over time?

Piotroski tests profitability, balance-sheet direction, and efficiency; Altman estimates bankruptcy risk. Compare the current scores with their fiscal-year history.

Financial strength scores

Piotroski F-Score and Altman Z-Score from the latest reported financials

Piotroski F-Score

Average

6 / 9

Nine pass/fail tests of profitability, balance-sheet strength, and efficiency. 8–9 is strong, 0–3 is weak.

Altman Z-Score

Safe zone

4.76

Bankruptcy-risk model. Above 2.99 is the safe zone, 1.81–2.99 the grey zone, and below 1.81 the distress zone.

Score history

Piotroski F-Score and Altman Z-Score recalculated from each fiscal year's statements and year-end market value.

Piotroski: 8–9 strong, 4–7 average, 0–3 weak. Altman: above 2.99 safe, 1.81–2.99 grey, below 1.81 distress. Our calculation can differ slightly from the provider's current scores above.

Liquidity

Can it meet short-term obligations?

Check whether cash and current assets cover what falls due within a year without depending on fresh financing.

Cash & Equivalents

$167.31M

Q1 2026

3Y +3.1%1Y +2.2%

Quick Ratio

3.8x

Q1 2026

Current Ratio

3.8x

Q1 2026

Cash Ratio

2.7x

Q1 2026

Working capital

How quickly does cash come back?

Receivable, inventory, and payable days show how much cash the operating cycle ties up and whether that is changing.

Working capital and cash conversion

Annual days measures from year-end receivables, inventory, and payables against revenue and cost of revenue.

Working capital (Q1 2026)

$176.21M

Current assets − current liabilities

Days sales outstanding

112 days

+26 days vs prior year

Days inventory outstanding

22 days

+11 days vs prior year

Days payables outstanding

139 days

+32 days vs prior year

Cash conversion cycle

-5 days

+5 days vs prior year

Leverage

How much debt risk sits on the balance sheet?

Review total borrowings, debt relative to equity and assets, and whether operating profit covers interest costs.

Total Debt

$51.90M

Q1 2026

3Y +49.5%1Y +0.5%

Debt/Equity

0.2x

Q1 2026

Debt/Assets

0.1x

Q1 2026

Interest Coverage

154.3x

Q1 2026

Debt service

Can cash flow carry the debt?

Measure debt against EBITDA and free cash flow, see how much is due within 12 months, and follow debt and cash over time.

Debt service capacity

Can operating cash flow carry the debt, and how much is due soon?

Net debt

Net cash $115.41M

Total debt − cash − short-term investments

Net debt / EBITDA

Net cash

Above 3× is elevated

Free cash flow / debt

84.9%

Share of debt one year of FCF could repay

Years to repay debt

1.2 yrs

Total debt ÷ free cash flow

Operating cash flow / current liabilities

0.7×

Above 1× funds a year of obligations

Interest coverage

226.6×

Operating income ÷ interest expense

Debt maturity

Cash and short-term investments cover short-term debt 11.4×

Due within 12 months$14.63MDue later$31.45M

Balance sheet as of Q1 2026; cash flows TTM to Q1 2026.

Debt and cash over time

Fiscal-year-end borrowings against liquid assets; net debt below zero means net cash.

Balance sheet cushion

How much room is there if conditions weaken?

Extra cash and investments, and the balance of assets against liabilities, give the company room when trading gets harder.

Long-Term Investments

$1.20M

Q1 2026

3Y -62.6%1Y -97.9%

Assets

$388.02M

Q1 2026

3Y +7.2%1Y +2.0%

Liabilities

$117.64M

Q1 2026

3Y +18.5%1Y +0.4%

Balance sheet quality

Who funds the assets, and how tangible is the equity?

Split the claims on assets between suppliers, lenders, customers, and shareholders, and see how much equity rests on goodwill and intangibles.

Balance sheet quality

Who funds the assets, and how much of the equity is tangible (Q1 2026).

Claims on $388.02M of assets

  • Payables4.9%
  • Short-term debt3.8%
  • Long-term debt8.1%
  • Deferred revenue0.3%
  • Other liabilities13.2%
  • Equity69.7%

Goodwill + intangibles

$62.55M

16.1% of total assets

Share of equity

24.5%

Above 50% leaves little tangible backing

Tangible equity

$192.79M

Equity left after writing off goodwill and intangibles

Deferred revenue

$1.01M

Customer prepayments: a liability settled by delivering service, not cash

Shareholder claims

What do shareholders take out of the cash?

Dilution, stock-based pay, dividends, and buybacks all draw on cash flow; check whether free cash flow funds them.

Shareholder claims on cash

Dilution, stock-based pay, and whether free cash flow funds what is returned to shareholders.

Diluted shares, yearly change

+89.8%

FY2022–FY2025 compound rate

Stock-based compensation

$0

0.0% of operating cash flow

Dividends paid

None

TTM to Q1 2026

Dividend / free cash flow

—

Above 100% means dividends exceed free cash flow

Buybacks

$5M

TTM to Q1 2026

Weighted diluted shares outstanding

Competitor health

How does SBC Medical Group Holdings Incorporated compare with peers?

Compare leverage, interest coverage, and liquidity ratios with similar companies.

Competitor Health

Peer financial health comparison

CompanyMarket CapD/ED/AssetsND/EBITDAInt. Cov.QuickCurrentCash

HealthStream, Inc.

HSTM:NASDAQ

$855.77M0.040.03Net cash—0.960.960.29

rYojbaba Co., Ltd. Common Shares

RYOJ:NASDAQ

$29.57M4.120.653.1324.081.401.420.57

Questions

Financial health questions

Common questions about SBC's balance sheet, answered from the reported figures.

Is SBC's balance sheet healthy?

SBC Medical Group Holdings Incorporated (SBC) has a current ratio of 3.82, a quick read on short-term liquidity.

How leveraged is SBC?

Debt to equity is 0.20, which helps judge how much financing risk sits on the balance sheet.